Caizio’s Post

Researchers from the National Institutes of Health (NIH) and Memorial Sloan Kettering Cancer Center (MSKCC) have unveiled an innovative AI model that predicts responses to immunotherapy. This model, called LORIS, integrates various clinical factors like age, cancer type, prior treatments, blood albumin levels, and neutrophil-to-lymphocyte ratio. By incorporating DNA sequencing data and tumor mutational burden, the AI accurately identifies patients likely to respond positively to immune checkpoint inhibitors. This breakthrough offers insights into both short and long-term survival outcomes across different cancer types. #Immunotherapy #AIModel

NIH, MSKCC researchers publish AI model for predicting immunotherapy responses

NIH, MSKCC researchers publish AI model for predicting immunotherapy responses

fiercebiotech.com

To view or add a comment, sign in

Explore topics